四川蓝光英诺生物科技股份有限公司 SICHUAN LANGUANG YINGNUO BIOLOGY TECHNOLOGY CO.LTD.
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Revotek Receives Clearance from the National Health Commission of China for the World First Clinical Trial for 3D Bioprinted Stem Cell Vascular Grafts 2022-02-21 22:30
Revotek Deploys Its Bioink Technology to Research Institutes 2021-04-29 21:30
1